from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2671/ribD

LFCtreatmentdescriptionclass of inhibitor

0.221

Amikacinug/mL Amikacintranslation

0.036

Cap5-10ug/mL Capreomycintranslation

-0.074

Rox10-50 ug/mL Roxithromycintranslation

0.224

SM2-5 ug/mL Streptomycintranslation

0.834

Tet5-10 ug/mL Tetracyclinetranslation

-0.397

Rif0.2-5ug/mL Rifampicintranscription

-0.219

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.438

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.531

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.727

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.232

Clofazimine10-13 ug/mL Clofaziminerespiration

0.210

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.732

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.125

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.040

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.435

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.298

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.307

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.689

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.014

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.090

KCN5-20 ug/mL Potassium cyaniderespiration

0.450

NaN30.2-2 mM Sodium aziderespiration

0.596

Nigericin50 uM Nigericinrespiration

0.503

TRC10-150 ug/mL Triclosanrespiration

-2.343

TRZ10-25 ug/mL Thioridazinerespiration

0.139

Valinomycin0.5-10 uM Valinomycinrespiration

0.602

ZnSO42 mM ZnSO4respiration

-0.527

menadione6-10 ug/mL Menadionerespiration

0.025

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.379

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.275

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.647

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.340

NRP_1Non-replicating persistence stage 1dosRassociated

0.013

Amp0.2mg/mL AmpicillincellWall

-0.016

Cephalexin20-100 ug/mL CephalexincellWall

0.170

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.151

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.438

EMB10-20 ug/mL EthambutolcellWall

0.054

Eta12-40 ug/mL EthionamidecellWall

0.089

INH0.2-0.4 ug/mL IsoniazidcellWall

0.135

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.509

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.414

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.277

BZA0.12 mg/mL BenzamidearomaticAmides

0.811

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.559

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.247

H2O24 mM hydrogen peroxideDNAdamaging

1.191

Levo10 ug/mL LevofloxacinDNAdamaging

-0.019

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.733

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.808

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.448

UVUV-irradiationDNAdamaging

-2.368

ARP41-4 ug/mL Antitubercular compound ARP4?

0.255

Antimycin12.5-50 ug/mL Antimycin A?

0.140

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.631

PA_110-50 ug/mL Antitubercular compound PA-1?

0.549

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.039

PA8240.2-2 ug/mL PA-824?

-0.109

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.125

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.082

Verapamil50 uM Verapamil?

0.292

mercaptoethanol2 mM 2-Mercaptoethanol?

0.049

methoxatin10-20 ug/mL Methoxatin?